Due to tumour relapse in vivo (Figure 2E), mice injected with MerTK-depleted A375p melanoma cells did not have longer survival (Supplementary Figure S6A), and isolated CQ-treatment did not induce tumour regression (Figure 6A). This evidence concerns the gene MERTK and neoplasm.